Pharmaceutical and Biotech Outsourcing R+D Expo and Conference

PABORD 2004 Tuesday 28th - Wednesday 29th September 2004, is the international exhibition and conference focussed exclusively on providing outsourcing solutions for pharmaceutical, biopharmaceutical and biotechnology companies active in the discovery and development of novel therapeutics This conference is completely free of charge for delegates , this is part of the current programme of speakers.

Keynote Presentation: The evolving role of CRO's in pharmaceutical and biotech outsourcing. Dr. Christopher Milne, Tufts Centre for Drug Development, USA.

Keynote Presentation: Outsourcing of complex multidisciplinary R&D programmes in drug development: benefits and challenges. Dr. David Cavalla, CEO, Arachnova, UK.

Partnering of early projects as a means to pipeline success. Dr. Roger Crossley, Director of New Product Development, Biofocus, UK

Moving to commercial production - challenges and methods for an economic upscaling. Dr. Markus Mersinger, Project Manager, FH-IPA, Germany.

Cost effective solutions for the manufacture of fermentation based biopharmaceuticals. Speaker TBC, Alberta Research Council, Canada.

Leveraging technology to manage transcontinental outsourcing. Dr. Swaminathan Subramaniam, CEO, Life Science Research, Sanmar Speciality Chemicals, India.

The BioIndustry Initiative: Creating Partnerships for the Biotechnology Sector in Russia. Dr. Jason E Rao, Program Director, Bioindustry Initiative, US Department of State.

Synergy. A successful case study for all with pharmaceuticals and biotechnology. Dr Ian McKinley, SRG Recruitment, UK

Phase IIIb/IV trials - Getting investigators on board, publication strategy and life cycle management. Dr. Robert Miller, Medical Director, Fulcrum Pharma Developments Ltd., UK.

Managing IP from outsourcing collaborations - early steps to avoid disputes. Mr. Hiroshi Sheraton, Solicitor, McDermott, Will and Emery, UK.

Bringing biotechnology to market through the device route. Mr. Neil Armstrong, Managing Director, MeddiQuest Ltd., UK.

Outsourcing pharma development out of China and India. Dream or reality? Dr Enrico Polastro, Vice President, Arthur D. Little, Benelux N.V/S.A.